Mast Cell-Derived Histamine Mediates Cystitis Pain

Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
PLoS ONE (Impact Factor: 3.23). 02/2008; 3(5):e2096. DOI: 10.1371/journal.pone.0002096
Source: PubMed

ABSTRACT Mast cells trigger inflammation that is associated with local pain, but the mechanisms mediating pain are unclear. Interstitial cystitis (IC) is a bladder disease that causes debilitating pelvic pain of unknown origin and without consistent inflammation, but IC symptoms correlate with elevated bladder lamina propria mast cell counts. We hypothesized that mast cells mediate pelvic pain directly and examined pain behavior using a murine model that recapitulates key aspects of IC.
Infection of mice with pseudorabies virus (PRV) induces a neurogenic cystitis associated with lamina propria mast cell accumulation dependent upon tumor necrosis factor alpha (TNF), TNF-mediated bladder barrier dysfunction, and pelvic pain behavior, but the molecular basis for pelvic pain is unknown. In this study, both PRV-induced pelvic pain and bladder pathophysiology were abrogated in mast cell-deficient mice but were restored by reconstitution with wild type bone marrow. Pelvic pain developed normally in TNF- and TNF receptor-deficient mice, while bladder pathophysiology was abrogated. Conversely, genetic or pharmacologic disruption of histamine receptor H1R or H2R attenuated pelvic pain without altering pathophysiology.
These data demonstrate that mast cells promote cystitis pain and bladder pathophysiology through the separable actions of histamine and TNF, respectively. Therefore, pain is independent of pathology and inflammation, and histamine receptors represent direct therapeutic targets for pain in IC and other chronic pain conditions.

Download full-text


Available from: Charles N Rudick, Aug 26, 2015
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: The design process of modern smart materials often require the use of complex system models. These models cannot be derived easily due to the complex knowledge that describe the process. In some cases, model parameters can be gained using neural networks, but these systems allow only a one-way simulation from input values to learned output values. If evaluation in the other direction is needed, these models allow no direct evaluation. This task can be solved using modern techniques like evolutionary algorithms and fuzzy logic. The use of such a combination allows evaluation of the learned simulation models in the direction from output to the input. An example can be given from the field of screw rotor design
    Intelligent Processing and Manufacturing of Materials, 1999. IPMM '99. Proceedings of the Second International Conference on; 02/1999
  • [Show abstract] [Hide abstract]
    ABSTRACT: Many patients with interstitial cystitis (IC) find that particular foods exacerbate disease symptoms. These patients may modify their diet to manage symptoms, but the mechanism by which dietary modification benefits patients with IC is unclear. We hypothesize that integration of neural signals from pelvic organs mediates the effects of diet on symptoms of IC. In animal models, pelvic inflammation is subject to crosstalk, so an inflammatory stimulus in one pelvic organ evokes a response in an independent organ. Recent data show that the colon can modulate bladder-associated pelvic pain in mice. As pelvic organs are innervated through shared circuitry, perceived pelvic pain might occur when spatial summation of individual pelvic inputs exceeds a threshold. Through this mechanism, a noxious dietary stimulus, which otherwise does not exceed the pain threshold in a normal individual, may substantially exacerbate pain in a patient with bladder symptoms. Repeated painful stimuli over time further contribute to symptoms by a process of temporal summation, resulting in enhanced responsiveness through central sensitization. Thus, pelvic organ crosstalk might modulate symptoms of pelvic pain by spatial and temporal summation, suggesting a mechanism for the benefits of dietary modification in patients with IC, as well as therapeutic opportunities.
    Nature Clinical Practice Urology 10/2008; 5(9):494-500. DOI:10.1038/ncpuro1203 · 4.07 Impact Factor
Show more